Gremubamab, CAS 1800381-36-5

Product Description: Gremubamab (MEDI3902) is a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody. Gremubamab binds to the PA PcrV protein and Psl exopolysaccharide. Gremubamab has the potential for the research of pseudomonas aeruginosa infections[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Chastre J, et al. Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial. Crit Care. 2022 Nov 15;26(1):355. /[2]Le HN, et al. Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa Bloodstream Infection and Acute Pneumonia Rabbit Models. Antimicrob Agents Chemother. 2019 Jul 25;63(8):e00710-19.

CAS Number: 1800381-36-5

Molecular Weight: N/A

Compound Purity: 95.0

Research Area: Infection

Solubility: 10 mM in DMSO

Target: Bacterial

• Artikelnummer: MEXHY-P99649-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99649-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated